Faculty who are involved with the M.S. program join an official Graduate School group titled a "graduate faculty body." The Clinical Research MS graduate faculty body currently consists of 53 faculty members. Additional faculty will be added as the program needs grow and specific skills are required.
The major draws faculty from the University's schools of public health, medicine, dentistry, nursing, pharmacy, and veterinary medicine. Faculty interests range over a broad set of topics. The following table lists areas of research expertise for full-time and adjunct faculty.
CR Faculty/Home Department |
Research Interests |
K. Scott Baker MD, MS
Hematology/Oncology; Pediatrics |
Long-term complications in survivors of childhood cancer or after hematopoietic stem cell transplantation |
Gregory Beilman, MD, FACS
Surgical Critical Care; Surgery |
Tissue energetics in hemorrhagic and septic shock; new monitoring strategies in the ICU; Novel treatments of sepsis; outcomes in ICU and surgical infections |
Alan Berger, MD
Cardiology: Medicine with an Adjunct Appointment with Epidemiology and Community Health |
Acute coronary syndromes and interventional catheterization. Utilization of reperfusion therapy for acute myocardial infarctions. |
Carole Bland, PhD
Family Practice/Community Health; Medical School |
Individual and institutional characteristics of research productivity, faculty development and educational program evaluation |
Donna Bliss, PhD, RN, FAAN
Nursing |
Effects of dietary fiber therapies on fecal incontinence; nutrition support - dietary fiber, tube feeding and diarrhea; prevention of perineal dermatitis associated with incontinence |
Hanna Bloomfield, MD, MPH
General Internal Medicine; VA Medical Center |
Health services and outcomes research, chronic disease, cardiovascular disease prevention and clinical trials |
Paul Bohjanen, MD, PhD
Microbiology Department |
T Lymphocyte mRNA Stability. Research focuses on the role of mRNA decay in regulating T lymphocyte activation and function. |
John Bond, MD
Medicine, VA Medical Center |
Colorectal cancer |
Linda Burns, MD
Hematology, Oncology, Transplantation; Medicine |
Clinical trials research; hematopoietic stem cell transplantation; hematologic malignancies; immunotherapy |
Jay N. Cohn, MD
Cardiovascular Division, Rasmussen Center for Cardiovascular Disease Prevention |
Congestive heart failure diagnosis and treatment, hypertension, early detection of CV disease, arterial compliance |
Allan Collins, MD
Renal Diseases and Hypertension; Medicine; Director, Chronic Disease Research Group, Minneapolis Medical Research Foundation |
Observational studies using large registry databases for kidney disease patients; causes and consequences of anemia and other complications of end-stage renal disease |
Daniel Duprez, MD, PhD
Cardiology; Medicine |
Clinical trials cardiology, primary and secondary prevention, arterial stiffness, lipid disorders, arterial hypertension, peripheral vascular disease, cardiovascular risk scores. New techniques for early detection of cardiovascular disease |
Maurice Dysken, MD
Psychiatry; GRECC Program, VA Medical Center |
Clinical trials with Alzheimer patients for treatment of cognitive impairment and/or behavioral problems: delirium assessment and prevention |
Kristine Ensrud, MD, MPH
Epidemiology/Medicine; VA Medical Center |
Epidemiology of chronic diseases with focus in osteoporosis prevention and treatment, management of menopausal symptom, sleep disorders |
Patricia Fontaine, MD, MS
Family Practice/Community Health; Medical School |
Cervical cancer screening. Perinatal and newborn care, including pain management for labor. Practice-based research networks. |
Edward Greeno, MD
Hematology, Oncology, Transplantation; Medicine |
Clinical trials involving prevention of thrombosis and in active treatment of solid tumor malignancies |
Richard Grimm, MD, PhD
Berman Center; Hennepin County Medical Center |
Clinical trials on hypertension, lipids, CV risk; women’s Health and complementary and alternative medicine |
David Hardten, MD
Ophthalmology; Medical School |
Diseases of the eye |
Dorothy Hatsukami, PhD
Psychiatry; Medical School |
Behavioral pharmacology and treatment of nicotine addiction; toxicity of tobacco products |
Timothy D. Henry, MD
Interventional Cardiology, Director of Research, Minneapolis Heart Institute Foundation |
Acute myocardial infarction, interventional cardiology, angiogenesis, stem cell research, clinical trials |
Alan T. Hirsch, MD
Vascular Medicine and Cardiology; Epidemiology and Community Health; School of Public Health; Medical School; and Minneapolis Heart Institute Foundation |
Epidemiology of peripheral arterial disease (PAD); clinical trials of PAD pharmacotherapies, endovascular interventions, and tobacco cessation interventions to improve non-coronary vascular outcomes; clinical trials of lipid and hypertension cardiovascular risk reduction interventions; evaluation of quality-of-life in vascular diseases; health economics of PAD. |
Andrew Huang, MD
Ophthalmology; Medical School |
Corneal diseases |
Hassan Ibrahim, MD, MS
Renal Diseases and Hypertension; Medicine |
Clinical research in progressive renal disease, diabetic nephropathy and chronic renal transplant rejection |
Ajay Israni, MD, MS
Renal Division, Department of Medicine |
Molecular epidemiology and renal transplantation, outcomes in renal transplantation and end-stage renal disease |
Jeffrey Kahn, PhD, MPH
Center for Bioethics |
Bioethics, including ethics of human subject research, ethics and genetics, ethics and biotechnology, ethics and public health |
Joseph Keenan, MD
Family Practice/Community Health; Medical School |
Cardiovascular heart disease, home care and nutrition |
Nigel Key, MB, ChB, FRCP
Hematology, Oncology, Transplantation; Medicine |
Hemostasis and thrombosis |
Robert Kratzke, MD
Medicine, Hematology Office |
Molecular abnormalities in lung cancer and mesothelioma, focusing primarily on cell cycle regulator genes and their loss of function in cancer. |
Frank A. Lederle, MD
Medicine; VA Medical Center |
Management of abdominal aortic aneurysms, evidence-based medical decision-making, clinical trial methodology |
John Look, DDS, MPH, PhD
Diagnostic and Biological Sciences |
Temporomandibular joint disorders |
Russell Luepker, MD, MS
Epidemiology and Community Health; Public Health |
Cardiovascular disease epidemiology and clinical trials |
Karen Margolis, MD, MPH
HealthPartners Research Foundation |
Cardiovascular disease epidemiology and prevention, women’s health, diabetes epidemiology, prevention and treatment |
Philip McGlave, MD
Medicine |
Experimental therapy for malignant and non-malignant hematologic disorders including stem cell transplantation, immunotherapy, and gene transfer. |
Ann Mertens, PhD
Epidemiology and Clinical Research; Pediatrics |
Childhood cancer etiology, and late effects in childhood cancer survivors |
Antoinette Moran, MD
Endocrinology; Pediatrics |
Diabetes mellitus/cystic fibrosis |
James Neaton, PhD
Biostatistics; Public Health |
Randomized clinical trials - HIV treatment, hypertension, and heart failure trials |
Joseph Neglia, MD, MPH
Pediatrics, Division of Hematology/Oncology/Bone Marrow Transplantation |
Long-term effects of cancer therapy. Occurrence of second malignancies following childhood cancer. |
Thomas Nevins, MD
Nephrology; Pediatrics |
Medication compliance, solid organ transplantation, nephrology |
Mark Paller, MD, MS
Renal Diseases and Hypertension; Medicine |
Clinical trials management; clinical research in acute renal failure, renal and electrolyte disorders |
Mark Pereira, MPH, PhD
Epidemiology; Pblic Health |
Nutrition and physical activity in the prevention of obesity, type 2 diabetes and cardiovascular disease |
Bruce Peterson, MD
Hematology, Oncology, Transplantation; Medicine |
Clinical research/Hematologic malignancies |
Anna Petryk, MD
Department of Pediatrics |
Mammalian development and the molecular mechanisms underlying tissue differentiation and organogenesis. Endocrine late effects in long term survivors of cancer and/or bone marrow transplantation, |
Julie Ross, PhD
Division of Pediatric Epidemology & Clinical Research; Department of Pediatrics |
Molecular epidemiology and etiology of malignancies in both children and adults, particularly in the area of leukemia |
David Rothenberger, MD
Department of Surgery; Colon/Rectal Surgery |
Rectal cancer; Familial Colorectal cancer; Clinical research in a managed care environment |
Timothy Schacker, MD
Infectious Diseases and International Health; Medicine |
HIV transmission and nature history of Hepes Simplex Virus Infection |
S. Charles Schulz, MD
Department of Psychiatry |
Schizophrenia, borderline personality disorder, psychiatric illnesses in adolescents, brain imaging |
Elizabeth Seaquist, MD
Endocrinology and Diabetes; Medicine |
Diabetes and diabetes complications |
Julia Steinberger, MD, MS
Pediatrics, Division of Cardiology |
Metabolic syndrome in youth
|
William Thomas, PhD
Biostatistics; Public Health |
Clinical trials |
Carolyn Torkelson, MD, MS
Family Medicine and Community Health |
Complementary/alternative medicine, women’s health, nutrition, probiotics |
Todd Tuttle, MD
Surgery, Oncology |
Clinical trials evaluating therapies for breast cancer, melanoma, and gastrointestinal malignancies |
Daniel Weisdorf, MD
Hematology, Oncology, Transplantation; Medicine |
Clinical bone marrow transplantation and management of hematologic malignancy |
Mark Yeazel, MD, MPH
Family Practice/Community Health; Medical School |
Colorectal cancer screening, Childhood cancer survivors, Clinical research related to cancer prevention and detection |
Douglas Yee, MD
Hematology, Oncology, Transplantation; Medicine |
Breast cancer: on insulin growth factors (IGF) in breast cancer, including their signaling pathways and receptors |